Proton therapy utilizes the physics characteristics of protons, which have well-defined ranges in a medium, to conformally deposit radiation energy to target volumes without exit doses1,2. This feature decreases the toxicity to healthy tissues such that patients who received proton therapy have lower risks of unplanned hospitalization compared to those who received photon treatment3. However, proton range uncertainty 4 requires additional margins for robust treatment planning5,6, which may compromise the sparing of healthy tissues when organs at risk (OAR) are closely adjacent to the treatment target. In the era of precision medicine, the critical question is how to minimize the radiation doses to OARs such that planning constraints are no longer dose-limiting for typical target prescription doses.
Favaudon et al. demonstrated that ultra-high dose-rate (≥ 40 Gy/sec) radiation, the so-called FLASH effect, (TCP) 7, can preferentially spare normal tissues from acute radiation-induced apoptosis, while maintaining similar tumor control 8. This promising finding can potentially make a paradigm shift in radiotherapy, and the FLASH effect has been explored in several settings since its discovery9–11. Proton FLASH therapy has been investigated regarding the feasibility of using the current commercial treatment delivery system and inverse planning12–14. Meanwhile, the efficiency and accuracy of image-guided systems are important due to high dose and ultra-high dose rate of FLASH delivery15. On-board fast imaging systems are essential to detect potential patient anatomy changes and for motion management, especially for patients with lung targets. However, the current proton on-board cone-beam computed tomography (CBCT) images require 30–60 seconds of scan time, and their quality can be compromised due to motion and artifacts.
Commercial proton machines, such as Varian ProBeam and IBA Proteus®ONE, include two kV x-ray sources with an image acquisition time of less than a second. The two orthogonal kV projections can potentially be acquired simultaneously, and the volumetric reconstruction method based on these projections will be free of motion and cavity artifacts. However, image reconstruction based on two projections is ill-conditioned16. This ill-posed problem poses a challenge for conventional image reconstruction methods. In contrast, deep learning (DL) has been demonstrated as a universal approximator17, and DL models feature in hierarchical learning to discover the underlying patterns behind the data18. A significant challenge of applying DL to medical volumetric image reconstruction is the identification of tumor regions due to information lost when superimposing three-dimensional (3D) volumetric images to 2D projections19.
Many researchers have investigated various DL models to reconstruct 3D volumetric images based on limited 2D information20–22. One approach uses deformable image registration techniques to register 2D and 3D images23. A recent development24 integrates DL and mechanical models to achieve real-time liver tumor localization. However, the previous literature is usually based on a single x-ray projection, and the robustness of DL models in terms of CT numbers for dose evaluation remains an open question.
This study proposes a DL-based image-guide framework to inform the potential proton FLASH treatment, including tumor position and patient anatomy changes. We use two orthogonal x-ray projections to provide additional information to enhance the predictability of DL models. Most importantly, we integrate a ray tracing-based water equivalent thickness (WET) evaluation module into the proposed framework for treatment feasibility investigation. This module can specifically detect potential anatomy changes corresponding to proton beams. To evaluate the proposed framework, we investigate under which conditions the volumetric images can be derived effectively, accurately, and robustly to support medical decision-making.